PDF] Thromboprophylactic treatment with rivaroxaban or dabigatran compared with enoxaparin or dalteparin in patients undergoing elective hip- or knee replacement surgery | Semantic Scholar
Guidance on converting between anticoagulants
How to switch from rivaroxaban to LMWH? | Download Scientific Diagram
Dose of XARELTO for Switching From Another Anticoagulant During Initial DVT or PE Treatment
Bridging the Gap: How to Transition from the NOACs to Warfarin - PDF Free Download
Care Transitions in Anticoagulation Management for Patients With Atrial Fibrillation: An Emphasis on Safety | Ochsner Journal
How to switch from rivaroxaban to LMWH? | Download Scientific Diagram
Transition of Anticoagulants 2014
Oral anticoagulants in the management of venous thromboembolism | Nature Reviews Cardiology
Cureus | Clinical Outcomes and Costs of Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Inpatients: A Cross-Sectional Study
Cureus | Current Trends in the Duration of Anticoagulant Therapy for Venous Thromboembolism: A Systematic Review
Time for a change? Switching anticoagulants in patients with AF or VTE | Thrombosis Adviser
Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons | The BMJ
Effectiveness and Safety of Standard- and Low-Dose Rivaroxaban in Asians With Atrial Fibrillation - ScienceDirect
Xarelto® Rivaroxaban The first oral direct factor Xa inhibitor - ppt download
Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons | The BMJ
Aspirin and an oral anticoagulant – can they be used together? - NPS MedicineWise
Apixaban starting dose after 1 week LMWH therapy (PE or DVT)? | ResearchGate
Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges | Journal of the American Heart Association